News & HighlightsNews
Mice with patchy coats lay bare how stem cells endure
Scientists have discovered how stem cells in the skin maintain their ability to replenish themselves, a process critical for hair growth. The findings suggest that errors in stem cell maintenance might contribute to permanent hair-loss conditions.
The gene hunt to explain why some young, healthy people die from COVID-19
People under 50 without preexisting conditions typically develop mild symptoms of coronavirus infection—but there are exceptions. Researchers are working to identify rare genetic variations that may explain why some in this group have succumbed to the disease.
Scientists are using ‘elite’ antibodies from COVID-19 survivors to develop potent therapies

Most people infected with the coronavirus are able to fight it off because their immune system produces effective antibodies. Rockefeller scientists are working to turn such antibodies into a drug.

Study captures the molecular architect of cells’ infrastructure
Using atomic-resolution technology, scientists have constructed the most detailed view yet of the molecular complex that decides where microtubules form.
3D imaging of blood vessels could shed new light on cardiovascular disease
The new imaging technique enables researchers to construct a comprehensive image of blockages and other vascular injuries.
Rockefeller scientists launch a broad range of studies into novel coronavirus
Over 130 scientists in 18 labs are conducting research to advance the development of new, urgently needed approaches for the prevention and treatment of COVID-19.
How skin cells embark on a swift yet elaborate death
Scientists have identified the mechanism that allows skin cells to sense changes in their environment, and very quickly respond to reinforce the skin's outermost layer. The findings provide insight into how errors in this process might lead to skin conditions like psoriasis.  
Research on soldier ants reveals that evolution can go in reverse
Turtle ant soldiers and their oddly-shaped heads suggest that evolution is not always a one-way street toward increasing specialization.
Rockefeller grants commercial license for the development of new HIV drugs
The novel compounds are based on so-called broadly neutralizing antibodies, molecules that make rare people's immune systems capable of fighting HIV. They could potentially yield new treatment and prevention approaches benefitting people around the world, including in developing countries.
Neuron-like activity detected in an unforeseen place
Scientists have identified a particular type of skin cell that looks and behaves similar to a nerve cell, prompting new questions about the body's biggest organ.
View
View